Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EGFR and ErbB2 differentially regulate Raf-1 translocation and activation.

Lianfeng Zhang1, Mary Bewick, Robert M Lafrenie

  • 1Division of Tumor Biology, Northeastern Ontario Regional Cancer Centre, 41 Ramsey Lake Road, Sudbury, Ontario, Canada P3E 5J1.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|January 18, 2002
PubMed
Summary

Epidermal growth factor receptor (EGFR) and ErbB2 influence Raf-1 signaling in breast cancer. ErbB2 overexpression retains Raf-1 at the plasma membrane, prolonging MAP kinase activation and potentially increasing cancer malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytochrome P450 2E1 aggravates DXR-induced myocardial injury through imbalanced mitochondrial OPA1.

Cell communication and signaling : CCS·2025
Same author

Establishment and characterization of liver-specific Apoa4-Cre and Cyp2c11-Cre rat models in juvenile and adult stages.

Animal models and experimental medicine·2025
Same author

Transcriptomic analysis reveals decreased expression of detoxification genes in Caenorhabditis elegans exposed to mepanipyrim and cyprodinil: Implications for multigenerational exposure effects.

Ecotoxicology and environmental safety·2024
Same author

Correction to: WIF1 causes dysfunction of heart in transgenic mice.

Transgenic research·2024
Same author

Insights into the Injectivity and Propagation Behavior of Preformed Particle Gel (PPG) in a Low-Medium-Permeability Reservoir.

Gels (Basel, Switzerland)·2024
Same author

Evaluation of Profile Control and Oil Displacement Effect of Starch Gel and Nano-MoS<sub>2</sub> Combination System in High-Temperature Heterogeneous Reservoir.

Gels (Basel, Switzerland)·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) and HER-2/ErbB2 are key signaling receptors in the Erb family.
  • ErbB2 overexpression is common in cancers and associated with increased tumor malignancy.
  • Understanding signal transduction pathways is crucial for cancer research.

Purpose of the Study:

  • To investigate the cellular translocation of Raf-1 during EGF-dependent signal transduction.
  • To determine the role of ErbB2 in regulating Raf-1 localization and activation.
  • To explore the impact of ErbB2 on MAP kinase cascade activation in breast cancer cells.

Main Methods:

  • Utilized two breast tumor cell lines: BT20 (EGFR-expressing) and SKBR3 (EGFR and ErbB2-expressing).

Related Experiment Videos

  • Examined cellular translocation of Raf-1 and EGFR upon EGF stimulation.
  • Employed gene transfection to confirm the role of ErbB2 in Raf-1 retention.
  • Assessed activation of Raf-1 and MAP kinase.

    • Main Results:

    • In BT20 cells, EGF induced rapid EGFR and Raf-1 accumulation in vesicles, with Raf-1 later dissociating to the cytosol.
    • In SKBR3 cells, EGF stimulation led to EGFR/Raf-1 vesicle accumulation, but EGFR endocytosis was inhibited, and Raf-1 remained at the plasma membrane.
    • ErbB2 transfection in BT20 cells mimicked SKBR3 cells, prolonging Raf-1 plasma membrane association.
    • Prolonged Raf-1 presence at the plasma membrane correlated with sustained Raf-1 and MAP kinase activation.

    Conclusions:

    • ErbB2 expression promotes the retention of Raf-1 at the plasma membrane.
    • This retention leads to prolonged activation of the MAP kinase cascade.
    • Sustained MAP kinase activation due to ErbB2 may contribute to enhanced malignancy in ErbB2-expressing cancers.